New daily pill shows promise for controlling stubborn eczema in real life
NCT ID NCT05689151
First seen Jun 24, 2026 · Last updated Jul 08, 2026 · Updated 4 times
Summary
This study is tracking 183 adults with moderate-to-severe atopic dermatitis (eczema) who are taking abrocitinib, a daily tablet. Researchers want to see how well the drug works in real-life settings, not just in controlled clinical trials. Participants will be followed for 24 months with about 5 clinic visits to check skin improvement and safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- abrocitinib (a daily tablet)
- What this could lead to
- If successful, this study could confirm that abrocitinib is a safe and effective option for controlling moderate-to-severe eczema in real-world settings.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be less definitive. It also only follows patients for 24 months, so long-term effects remain unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH de Martigues
RECRUITINGMartigues, 13698, France
-
CHU Amiens-Picardie - Site Nord
RECRUITINGAmiens, Somme, 80080, France
-
CHU Besancon - Hopital Jean Minjoz
RECRUITINGBesançon, 25000, France
-
CHU Brest Hopital Morvan
RECRUITINGBrest, 29609, France
-
CHU Clermont Ferrand - Hopital Gabriel Montpied
RECRUITINGClermont-Ferrand, 63000, France
-
CHU Lyon Sud
RECRUITINGPierre-Bénite, 69495, France
-
CHU Montpellier
RECRUITINGMontpellier, 34295, France
-
CHU Nancy
RECRUITINGVandœuvre-lès-Nancy, 54511, France
-
CHU de Caen
RECRUITINGCaen, 14033, France
-
Ch William Morey
RECRUITINGChalon-sur-Saône, 71100, France
-
Ch de Calais
RECRUITINGCalais, 62107, France
-
Ch de Romans Sur Isere
RECRUITINGRomans-sur-Isère, 26102, France
-
Ch de Valenciennes
RECRUITINGValenciennes, 59322, France
-
Chi Poissy Saint Germain En Laye
RECRUITINGSaint-Germain-en-Laye, 78105, France
-
Chu Bordeaux Hopital Saint Andre
RECRUITINGBordeaux, 33075, France
-
Chu Dijon
RECRUITINGDijon, 21000, France
-
Chu Estaing
RECRUITINGClermont-Ferrand, 63003, France
-
Hopital Bégin
RECRUITINGSaint-Mandé, 94160, France
-
Hopital Charles Nicolle
RECRUITINGRouen, 76031, France
-
Hopital Claude Huriez
RECRUITINGLille, 59000, France
-
Hopital Cochin
RECRUITINGParis, 75014, France
-
Hopital Emile Muller
RECRUITINGMulhouse, 68070, France
-
Hopital Franco Britannique
RECRUITINGLevallois-Perret, 92300, France
-
Hopital Henri Mondor
RECRUITINGCréteil, 94010, France
-
Hopital Hotel Dieu
RECRUITINGNantes, 44000, France
-
Hopital Larrey
RECRUITINGToulouse, 31000, France
-
Hopital Pontchaillou
RECRUITINGRennes, 35033, France
-
Hopital Saint Louis (APHP) - Service Hematologic Senior
RECRUITINGParis, 75475, France
-
Hopital Tenon
RECRUITINGParis, 75020, France
-
Polyclinique Reims Bezannes
RECRUITINGBezannes, 51430, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection calm severe eczema when creams fall short?
- Can a new biologic calm severe eczema?
- Can a daily probiotic soothe colicky babies and calm eczema?
- Can a new injection match an existing eczema treatment?
- Can Real-World data unlock better skin disease care?
- Can a meditation app soothe teen eczema?